chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chest pain; the racing of the heart/palpitations; This is a spontaneous report received from a contactable consumer (patient) via a team. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number unknown), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. No medical history and concomitant medications were reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation and experienced chest pain, racing heart, and elevated blood pressure. Patient had some concerns about the Pfizer COVID-19 vaccine. Patient stated that he usually never gets sick with and had flu every 5 to 7 years. Patient stated that he usually gets sick for no longer thang 3 days and have not had any flu or common flu for 9 years and normally does not get sick. Patient stated that he would be last person who would need vaccine and took vaccine to protect everyone as he works for a utility and had to go to multiple homes. It was reported that on an unspecified date, the racing of the heart/palpitations and chest pain which patient experienced after first dose, had become more persistent after second dose and symptoms comes and goes but more persistent now. Patient did not have any other symptoms like fever or sore arm. Patient stated that he booked appointed with cardiologist. Patient stated that he had some financial issue and had an insurance highly deductible and must pay huge amount out of his pocket. Patient wanted to know if Pfizer supports the medical bills and received response that the program is a program that has been created to help pay for related costs of medical care and other specific expenses to compensate people injured after use of certain medical countermeasures. Medical countermeasures are specific vaccines, medications, devices, or other items used to prevent, diagnose, or treat the public during a public health emergency or a security threat. For more information about the program regarding the Pfizer-BioNTech COVID-19 Vaccine used to prevent COVID-19". Patient stated that he had a co-worker who got vaccine and ended up having same issue. The outcome of the events was unknown.   Information about batch/Lot number has been requested.
Child and parent presented together for vaccinations. Environment chaotic. Likely that child received adult vaccine.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Lymph Node Swelling-Mild
Per report (patient has switched PMD) patient began with seizure after 4 mo old shots (1st seizure with fever by report, following seizures not with fever pervious MD).
I gave the Pfizer COVID-19 vaccine, instead of the Moderna COVID-19 vaccine, for the patient's second dose.
On November 10th patient received influenza, PNEUMOVAX, and Td vaccines. On November 11th, he presented to the emergency room with muscle pain, chills, fever, nausea, and cramping. He was admitted to inpatient on November 11th, requiring IV fluids and IV clindamycin therapy. MD could not rule out probable immunologic reaction to the PNEUMOVAX with fever and hypotension in his differential diagnosis. Patient was discharged to home on 11/13/16 with prescription for cephalexin 500 mg PO four times a day x 3 days.
This spontaneous report was received from a nurse via Pfizer (manufacturer control #71932MZX), referring to a male patient of unknown age. The patient's concomitant medications, medical history, concurrent conditions, drug and allergy history were not reported. On an unspecified date, the patient was vaccinated with PNEUMOVAX 23 (strength, dose, route, lot # and expiration date were not provided) for prophylaxis. The nurse stated that, on an unspecified date, the patient was having side effects (adverse event) and was not feeling well (malaise). The outcome of adverse event and malaise was unknown. The causality assessment was not provided.
Patient state that she had a rash on her arm and was itching. Patient was instructed to take a benadryl and if rash got worse to report to ER.
Pt has a rash on the right arm, Pt gets flashes of heat/zing on occasion. Pt has no blistering, severe pain, and only occassionally itching.
Headache, Palpitations, chills, body aches, abdominal cramps Narrative:
Double vision upon awakening on June 2. Went to ER for MRI to rule out stroke. Diagnosed with  cranial nerve 3 palsy by ophthalmologist, Still having double vision, wearing a patch on right eye.
chest tightness and nausea, hyperventilation, 1st dose pfizer vaccine @ 1610, benadryl 25 mg IM given
Systemic: Lymph Node Swelling-Severe, Additional Details: Patient called and made us aware that she noticed her lymph nodes got inflammed and noticed it on Nov. 3, 2021 and she saw her primary care doctor and complained of inflammed lymph nodes on her collar bone and armpit that measured 1.5 inches thick. She also complained of slight nausea after the vaccine. She is still under observation by her PCP and she'll inform us on any update on her condition.
Large red indurated local reaction to (R) arm at Varivax site (SQ) painful, warm.
Okayed by Private MD 2:45 PM Gave patient COVID  shot after Dr okayed vaccine since patient has allergies to pollen, grass, flu shot ingredients.  States above causes breathing problems, migraines, heart flash. 0 PM patient complained of instat headache, sensitivity to light, and "feeling hot."  Patient talking, laughing throughout time. At 3:03 Dr ordered Benadryl 25 mgm liquid to be given.  VS  BP 133 86, HR 83 & Resp 20.  Discharged without event.
Left deltoid with swelling, erythema, increasing tenderness and warm to touch at the site. Edema of left shoulder girdle and tenderness radiates out from site.
Severe headache and abdominal cramping the day after on 3/19. Followed by worsening cramps and vaginal spotting from Saturday 3/20, Sunday 3/21, Monday 3/22 and Tuesday 3/23. Ultrasound was done on 3/23/21 at 14 weeks 1 day pregnant and no fetal heartbeat was found. EDD was 9/20/21
Typical sore arm after receiving the Moderna vaccines; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Typical sore arm after receiving the Moderna vaccines) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028K21A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE on 27-Jan-2021, PFIZER BIONTECH COVID-19 VACCINE on 17-Feb-2021 and PFIZER BIONTECH COVID-19 VACCINE on 20-Sep-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. Concurrent medical conditions included Drug allergy (Codeine).    On 01-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Typical sore arm after receiving the Moderna vaccines). At the time of the report, PAIN IN EXTREMITY (Typical sore arm after receiving the Moderna vaccines) had resolved.            No concomitant medication was reported.  No treatment information was reported.   This case was linked to MOD-2023-740870 (Patient Link).
Patient received above vaccines in office at approximately 11:20 am on 11/30/17. Started to get fever 102 at 6:30 pm that same evening, 11/30/17. Patient then had seizure with w to 3 minutes of whole body shaking, fever had increased to 104. Patient went to ER where treated with IV fluids, tylenol and ibuprofen. No further seizure activity.
Patient received the vaccine went to sit for the 15 min observation period and fainted about 5 mins after the vaccine was administered
hands swelling; right eye was involuntarily tearing; shaking; having a severe reaction, rash all over the body,extensive rash; red splashes all over their body except in their face and hands, smooth, not raised, not itchy,; fevers (102 ºF); chills/ felt a slight chill/ a little bit of chills; A spontaneous report was received from a Healthcare Professional concerning a 75-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a severe reaction, rash all over the body, chills, fevers (102 ºf), red splashes all over his body except in his face and hands, smooth, not raised, not itchy, shaking, right eye was involuntarily tearing and  hands swelling.  The patient's medical history included temporal arteritis ((4 years ago) which got inflamed and did not know the cause of it. The concomitant medications reported were Amlodipine 5 mg a day, Rapaflo 8 mg a day, Eliquis 5 mg twice a day, Flecainide 100 mg twice a day, and Metoprolol 25 mg a day (drug used for unknown indication).  On 15 Jan 2021 at about 10:45 am, prior to the onset of the events, the patient received his first of two planned doses of mRNA-1273 (lot batch: 012120A) via unknown for prophylaxis of COVID-19 infection.  On 22 Jan 2021, the patient felt a slight chill. However  On 23 Jan 2021, the patient had a severe reaction, rash all over the body, chills, fevers (102 ºf) and suddenly about late afternoon 5 PM noticed an extensive rash, red splashes all over his body except in his face and hands, which were smooth, not raised, and not itchy. He started getting chills and fevers (temperature 102 ºF). On 24 Jan 2021, the patient experienced shaking and, on 25 Jan 2021, the right eye was involuntarily tearing and noticed swelling of hands. On an unknown date the patient visited the dermatologist for rash, and his biopsy was done for the same. but the results were unknown.  Relevant Lab data included,  COVID test Negative for rapid and PCR.  Blood and urine test were done on unknown date and blood test was normal.  Treatment details included Tylenol and prednisone 40 mg.  Action taken with mRNA-1273 in response to the events was Unknown.   The outcome of events chills resolved. Other symptoms include rash all over the body, red splashes all over his body except in his face and hands, smooth, not raised, not itchy, and right eye was involuntarily tearing was Unknown.   The reporter assessed the events as related to the vaccine drug.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Presents to ED for evaluation of left shoulder redness and swelling. The patient reports he has been vaccinated against COVID-19, but 2 days ago, he received a booster shot. He reports that now he has some redness and swelling to the left shoulder at the site of his booster shot. Patient states it is not painful, does not hurt him, but it does itch a little bit.  He denies any redness streaking up the arm. His wife drew a border around the redness, and has not progressed past the border. Patient does have some erythema that is very warm to the touch to the left deltoid region. It is about 10 cm in diameter, indurated, there is no fluctuance. This may be a simple injection site reaction, however, this could also represent cellulitis. Started the patient on some Keflex.
Cards reflects the wrong lot numbers and we can not figure out which patient's records are wrong; The patients have not reported any adverse reactions; This spontaneous case was reported by a pharmacist and describes the occurrence of TRANSCRIPTION MEDICATION ERROR (Cards reflects the wrong lot numbers and we can not figure out which patient's records are wrong) and NO ADVERSE EVENT (The patients have not reported any adverse reactions) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7170B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced TRANSCRIPTION MEDICATION ERROR (Cards reflects the wrong lot numbers and we can not figure out which patient's records are wrong) and NO ADVERSE EVENT (The patients have not reported any adverse reactions). At the time of the report, TRANSCRIPTION MEDICATION ERROR (Cards reflects the wrong lot numbers and we can not figure out which patient's records are wrong) and NO ADVERSE EVENT (The patients have not reported any adverse reactions) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (The patients have not reported any adverse reactions) to be not related. No further causality assessment was provided for TRANSCRIPTION MEDICATION ERROR (Cards reflects the wrong lot numbers and we can not figure out which patient's records are wrong).    This case contains information for the 6th out of 16 adult patients described by the reporter. No concomitant information was reported. Reporter states, "16 Patients Vaccination Cards reflects the wrong lot numbers and cannot figure out which patient's records are wrong. All patients received the correct vaccine and bivalent dose. The error only involves documentation. They administered Bivalent boosters from Bivalent Lot numbers: 061F22A and AS7170B. They wrote AS7170B on all 26 patient's vaccination cards. Cannot distinguish which patients. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-696236 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-696236:Master case
Decreased appetite x 3 days, inconsolable x 2 days, very cross.
Have developed migraines, nose bleeds, swelling of legs, loss of circulation in legs since vaccine.
Confusion-Mild, Dizziness, Lightheadedness-Mild, and Foggy Headed-Mild.
Ocular shingles; Shingles on face; This case was reported by a physician via sales rep and described the occurrence of ophthalmic herpes zoster in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number 52R7X, expiry date unknown) for prophylaxis.   On 16th July 2019, the patient received Shingrix. On 31st July 2019, 15 days after receiving Shingrix, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the ophthalmic herpes zoster and shingles were unknown.   It was unknown if the reporter considered the ophthalmic herpes zoster and shingles to be related to Shingrix.  Additional details were received as follows: The patient was diagnosed with shingles on face and ocular shingles. The patient was referred to ophthalmologist. The reporter consented to follow up. The batch number of Shingrix was reported as 5227X, which was corrected to 52R7X as per sales data sheet.
Starting at around 30 hrs post vaccine, severe stomach cramps, light headed, nausea, and profuse waves of vomiting.  Worse than "flu like" symptoms.  but with severe vomiting, and not a high temperature.  Mostly sweaty, and weak. Too weak to move or it would create another round of vomiting, which would be 4-6 waves of vomiting within a 2 minute period. Eventually able to stay completely still laying on floor, for a couple hours at a time. Tried to sip micro amounts of water or anything would cause the cramping to start up again. This lasted for a full day and a half. Eventually the sleep came, then the healing began. Rehydrating, and eating saltines, and immune smoothie helped. Tums, and at night 2 tylenol PM
I experienced swelling in my throat after both COVID Moderna vaccines.  The swelling began almost immediately after each vaccine was given to me.  I took 50 mg of OTC Benadryl about an hour after receiving my first vaccine and the swelling went away several hours later.  Due to the swelling I experienced after my first dose, I took 25 mg of Benadryl 30 minutes before receiving my 2nd vaccine.  I still experienced swelling in my throat immediately after receiving the 2nd vaccine, however, it was less severe than it was with my 1st dose.  Within 8 hours after receiving my 2nd dose on 6/11/2021, I started experiencing chest pain on the left side of my chest as well as pain down my left arm.  The pain intensified through the night and over the weekend.  I took 800 mg of ibuprofen as well as low dose aspirin every few hours for pain.  My pain was not much better a few days later so I went to the ED on 6/14/2021.  I was seen by a cardiologist on 6/16/2021 who sent me for several outpatient cardiac tests.  I continued to use ibuprofen and low dose aspirin for the pain, however, it only reduced the severity of my pain.  About two weeks after my 2nd vaccine, I started having shortness of breath as well as the continued chest pain.  I went back to the ED on 7/7/2021 due to my symptoms.  I followed up with my cardiologist about a week later.  After receiving the results of my cardiac MRI, I was diagnosed with pericarditis.  My cardiologist started me on 30 mg of prednisone daily at the end of July.  My chest pain and shortness of breath continued and I was started on 0.6 mg of colchicine daily on August 9th, along with the prednisone.  I was also referred to a pulmonologist.  I saw him at the beginning of September.  He sent me for pulmonology testing and started me on an albuterol inhaler as needed.  I stayed on prednisone until the end of October due to my continued symptoms.  To date, I am still taking 0.6 mg of colchicine daily and have just been started on an Anoro Ellipta 62.5-25 mcg/actuation Dsdv inhaler daily to help manage my symptoms.  I continue to be cared for by my cardiologist as well as my pulmonologist for chest pain as well as shortness of breath.
Patient with 2 Moderna COVID vaccines who admitted with complication r/t COVID and COVID detected PCR.  Provider d/c note:  "Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) See below note for details re: this hospitalization.   Hospital Course: No notes on file  These were her acute medical issues addressed:   1. COVID-19 infection with resp insufficiency/ hypoxia. -- Vaccinated x 2. No booster doses. -- needed O2 per nasal canula but at discharge was stable on RA. -- she declined Remdesivir.   2. Acute L frontal CVA. -- Acute stroke w/u done when she had AMS. -- Neurology was following. -- ASA changed to Plavix. Cont statin. Permissible HTn the first few days. -- has associated IC atherosclerosis. No large vessel obstruction in carotid. -- MRI shows a small L frontal ischemic lesion.   3. Breakthrough seizures from medical non adherence. -- started on Keppra 500 mg BID. No recurrent seizures the rest of her hospitalization. -- received CTX + Metronidazole for ?aspiration event."
tested positive for Covid-19; tested positive for Covid-19; This is a spontaneous report from a contactable female consumer(patient) via Pfizer Sponsored Program. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. Medical history included asthma. The patient's concomitant medications were not reported. The patient tested positive for covid-19 on an unspecified date and experienced drug ineffective. She was wondering if she should still take the Covid-19 vaccine 2nd shot scheduled next day. She had her 1st dose of the vaccine 3 weeks ago. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on  unknown date. Outcome of events was unknown.  Information on the lot/batch number has been requested.
c/o pain numbness going down L arm with injection (in left arm).  Numbness, tingling severe within 15 min-Startes within 3 hours numbness @ L foot.  Next day bilat fee.  Went to ED- told she was having allergic reaction-gave BENADRYL.  2/9/09 to clinic- Neuro/vasc assesment WNL.  Went to MD 2/10 -> EMG WNL.  2/11-decreasing numbness lingering.
pt devel pain, swelling, induration, & fever 101.5; also had reduced ROM to lt arm; sx devel w/in 24 hrs p/shot & by 15JUN92 pt had fever, pain, & swelling; dx w/pneumonia;
Information has been received from a registered nurse concerning a 6 month old male who on 18-AUG-2008 was vaccinated with a dose of PNEUMOVAX 23 vaccine. Concomitant therapy included DTaP (+) tetanus toxoid and poliovirus vaccine. The nurse reported that the 6 month old child may have received PNEUMOVAX 23 vaccine. The office was not sure that the child received PNEUMOVAX 23 vaccine. The child developed fever up to 104 degrees Fahrenheit and vomiting with increased irritability within 7 hours of vaccination on 18-AUG-2008. The patient sought medical attention by telephone, but no treatment information was provided. At the time of reporting, the patient had not recovered. Additional information has been requested.
It was reported that a 45 year old female patient received a Fluzone SV vaccination on 10/16/2000 at 8:30 am. During the evening of 10/16/2000 the patient developed a large red circle on her left arm, that was raised and hot to the touch. In the morning of 10/17 the patient developed itching all over and her knees became red. Developed redness up to mid-chest. Also developed sores from the waist down. On 10/19 physician saw the patient. The patient's  recovery status is unknown. From additional correspondence received on 02/21/2001, it was reported that the patient is still in treatment. The correct vaccination time was also provided.
Missed second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided by the reporter. Treatment medication was not provided.; Sender's Comments: This case concerns a patient of unknown age or gender, with no reported medical history, who experienced the unexpected event of Product dose omission issue. The event occurred an unknown number of days after the first dose of mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
he was tired for 24 hours; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (he was tired for 24 hours) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In December 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (he was tired for 24 hours). At the time of the report, FATIGUE (he was tired for 24 hours) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medications were not provided by the reporter Treatment information was not provided.
After receiving the shot I noticed hives on my hand, didn?t think anything of it till later that night hives would appear on different areas of my body and last for about 20 min then go away. Right arm was sore next day and body was very achy